MedTrace Logo

Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After Discharge

NCT04368793 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-07-17

No results posted yet for this study

Summary

The noval coronavirus disease 2019 (COVID-19) would cause physical and psychological dysfunctions in infected patients. We expect that an intelligence-based remote pulmonary rehabilitation scheme could improve patients' health status after hospital discharge. The intelligence-based remote pulmonary rehabilitation program is designed in a real-world and prospective manner, aiming to evaluate the efficacy of rehabilitation among 200 patients in the epicenter of China (Wuhan City) according to their varied adherence. An eight-week rehabilitation scheme, including two weeks for physicians and physiotherapists remotely guided training, and six weeks for patient self-management, will be addressed. The primary outcome of current study is six-minute walking distance and lung function, and secondly respiratory muscle strength, physical fitness assessment, symptoms and quality of life, etc. will also be assessed. Recruited patients will be followed up at week 2, 4, 8 after enrollment and at month 1, 3, 6, 12 after the rehabilitation training completed, respectively. The study has been approved by the ethics committee of China-Japan Friendship Hospital and three participating centers in Wuhan City.

Conditions

  • COVID-2019 Pneumonia
  • Pulmonary Rehabilitation

Interventions

BEHAVIORAL

Remote pulmonary rehabilitation

The pulmonary rehabilitation intervention includes respiratory exercise, barehanded aerobic training, exercise prescription of elastic band impedance training, respiratory muscle strength training, etc.

Sponsors & Collaborators

  • Wuhan lung Hospital

    collaborator UNKNOWN

  • Wuhan Central Hospital

    collaborator OTHER

  • Wuhan University

    collaborator OTHER

  • Ai You Foundation

    collaborator UNKNOWN

  • China-Japan Friendship Hospital

    lead OTHER

Principal Investigators

  • Ting Yang, Prof. · China-Japan Friendship Hospital

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-06
Primary Completion
2020-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04368793 on ClinicalTrials.gov